Quarterly report pursuant to Section 13 or 15(d)

Basic and Diluted Net Loss Per Share (Tables)

Basic and Diluted Net Loss Per Share (Tables)

3 Months Ended

Mar. 31, 2021

Schedule of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of the Company’s basic and diluted net loss per share for:

	Three-months ended March 31, 2021 (Unaudited)
	Net Loss (Numerator)			Shares (Denominator)		Per share amount
Basic loss per share	$	(1,382,118	)		794,183	$	(1.74	)
Effect of dilutive securities—Common stock options, warrants, convertible notes, and preferred stock		-			-		-
Diluted loss per share	$	(1,382,118	)		794,183	$	(1.74	)

	Three-months ended March 31, 2020 (Unaudited)
	Net Loss (Numerator)			Shares (Denominator)		Per share amount
Basic loss per share	$	(1,002,868	)		700,879	$	(1.43	)
Effect of dilutive securities—Common stock options, warrants, and convertible notes		-			-		-
Diluted loss per share	$	(1,002,868	)		700,879	$	(1.43	)

Schedule of Shares of Common Stock Equivalents Were Excluded from Computation of Diluted Net Loss Per Share

The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have been antidilutive for the periods ended:

	March 31, 2021		March 31, 2020
	(Unaudited)		(Unaudited)
Common stock underlying convertible notes		688,147		443,410
Common stock underlying options		141,122		202,246
Common stock underlying warrants		901,199		447,036
Common stock underlying preferred stock		10,172		-
Total common stock equivalents		1,740,640		1,092,692